Abstract:OBJECTIVE:To investigate the expression of five apoptosis-related proteins, Fas, Fas ligand (FasL), Fas-associated death domain protein (FADD), caspase 8, and mutant p53, in human esophageal squamous cell carcinoma (ESCC) tissue, and analyze the association of these proteins with ESCC malignant progression. METHODS:116 ESCC specimens obtained during operation. Tissue microarray composed of the 116 specimens of cancerous tissues and corresponding paracancerous normal epithelium tissues was constructed. The expression of Fas, FasL, FADD, caspase 8, and mutant p53 was detected in the ESCC tissues and paracancerous normal epithelium tissues and analysis was conducted for the correlation between the expression of these proteins and the pathoclinical features and prognosis. involvement, differentiated grade, pTNM stages and disease-free survival. RESULTS:The positive rate of Fas in the ESCC tissues was 41.4%, significantly lower than that in the normal squamous epithelium was 95.7%, P < 0.001). The positive rates of FasL and FADD in the ESCC tissues were 76.7% and 50.0%, both significantly higher than those in the normal squamous epithelium (39.7% and 7.8%, both P < 0.001). Caspase 8 was strongly positive in the whole normal esophageal epithelium tissue except basal and superbasal cells, but negative in ESCC. Mutant p53 protein was negative in the normal esophageal epithelium tissue, with only several cases positive in the basal cells, but was diffusely positive in ESCC tissues with a positive rate of 37.1%. The expression of Fas in the well and moderately differentiated ESCC tissues was significantly higher than in the poorly differentiated ones (P = 0.022). The patients with positive expression of FADD had lower disease-free survival rate (P = 0.0028). The expression of Fas, FasL, caspase 8, and mutant p53 was not related with disease-free survival rate (P > 0.05). CONCLUSION:The apoptosis-related markers, such as Fas, FasL, FADD, caspase 8, and mutant p53 protein may play important roles in the development and progression of ESCC, and FADD can be used as a marker to predict the advance and prognosis of ESCC.

Implication of Polymorphisms in the Promoter Region of Apoptosis-Related Genes in Survival of Gastric Cancer Patients.

Functional polymorphisms in apoptosis pathway genes and survival in patients with gastric cancer.

[Expression of Fas, Fas Ligand, Fas-associated Death Domain Protein, Caspase 8 and Mutant P53 Protein in Esophageal Squamous Cell Carcinoma].

[Association Between Fas/Fas L Genes Promoter Polymorphisms and Pathogenic Risk of Cervical Cancer].

Association Of The Polymorphisms In The Fas/Fasl Promoter Regions With Cancer Susceptibility: A Systematic Review And Meta-Analysis Of 52 Studies

[Genetic Polymorphisms of Apoptosis-Associated Genes FAS and FASL and Risk of Colorectal Cancer].

Prognostic Role of Apoptosis-Related Gene Fas-1377 And-670 Polymorphisms in Breast Cancer

Prognostic Assessment of Apoptotic Gene Polymorphisms in Non-Small Cell Lung Cancer in Chinese

Apoptotic Variants As Predictors Of Risk Of Oropharyngeal Cancer Recurrence After Definitive Radiotherapy

Functional Polymorphisms in Cell Death Pathway Genes FAS and FAS Ligand and Risk of Prostate Cancer in a Chinese Population.

Genetic Polymorphisms in Genes Regulating Cell Death and Prognosis of Patients with Rectal Cancer Receiving Postoperative Chemoradiotherapy

Functional Polymorphisms in FAS/FASL System Contribute to the Risk of Occurrence but Not Progression of Gastric Cardiac Adenocarcinoma.

Single Nucleotide Polymorphisms in Apoptosis Pathway Are Associated with Response to Imatinib Therapy in Chronic Myeloid Leukemia

Clinical Significance of Expression of Apoptotic Signal Proteins in Gastric Carcinoma Tissue.

Expression Status of Fatty Acid Synthase (FAS) but Not HER2 is Correlated with the Differentiation Grade and Prognosis of Esophageal Carcinoma.

Polymorphism of the Programmed Death-Ligand 1 Gene is Associated with Its Protein Expression and Prognosis in Gastric Cancer

Clinical Significance of Fas, VEGF, and EGFR Expression in Advanced Gastric Carcinoma.

Altered Expression of Survivin, Fas and FasL Contributed to Cervical Cancer Development and Metastasis.

Caspase 8 Polymorphisms Contribute to the Prognosis of Advanced Lung Adenocarcinoma Patients after Platinum-Based Chemotherapy

Survivin Expression in Esophageal Cancer: Correlation with P53 Mutations and Promoter Polymorphism.

Genomic variants in Fas-mediated apoptosis pathway predict a poor response to Platinum-based Chemotherapy for Chinese Gastric Cancer Patients